Choose another ingredient

THE INGREDIENT LIBRARY · Entry 574

Beta-sitosterol-rich phytosterol preparation

A closed green supplement jar and two pale oval softgels
Decorative illustration of Beta-sitosterol-rich phytosterol preparation; generic packaging where shown, not a product or identification reference.

At a glance

A beta-sitosterol-rich mixture has limited human evidence for urinary symptoms.

Key cautions

  • Have urinary symptoms assessed before use.
Read the full cautions

What’s inside

Plant sterols are cholesterol-related compounds. The inspected trial abstract identifies a phytosterol mixture but does not give a complete batch specification.

Uses in brief

  • Symptom support: A studied sterol preparation improved BPH symptom scores and urine flow over six months.

History, folklore and reported uses

History, folklore and traditional uses

Isolated phytosterol research grew from twentieth-century lipid studies. A 1995 BPH trial provides this record’s main clinical link, rather than an ancient herbal tradition.

Traditional, historical and reported uses

  1. BPH trial history
    Human researchWhy this label?

    Reported use or research history, with the form and evidentiary limits stated in the entry. This label is not a treatment endorsement.

    The six-month placebo-controlled trial reported better symptom scores and urine flow, without an important prostate-size reduction.

  2. Cholesterol research context
    Historical recordWhy this label?

    Reported use or research history, with the form and evidentiary limits stated in the entry. This label is not a treatment endorsement.

    The NTP background report traces sitosterol cholesterol research to the 1950s. Those lipid findings do not prove that this BPH mixture prevents heart attacks.

Only documented uses and research history are included. Modern study products do not inherit ancient clinical evidence.

Story sources

Health topics: evidence and cautions

These notes describe a specific research context and preparation. A topic link is not a treatment recommendation.

Prostate health · Symptom support

Form and route: Oral non-glucosidic phytosterol preparation studied in BPH · oral

A studied sterol preparation improved BPH symptom scores and urine flow over six months.

Evidence: Limited clinical evidence

A placebo-controlled trial of 200 men found improved symptoms and flow, but no important decrease in prostate size.

Limits

An older trial of a specified mixture cannot establish all products, long-term safety or prevention of complications.

Cautions

  • Have urinary symptoms assessed before use.
  • Ask a pharmacist to review the exact product and other medicines.

Read the full Prostate health topic record

Identity & detailed reference

Identity

A beta-sitosterol-rich, phytosterol preparation studied orally for BPH. It is a mixture, not pure beta-sitosterol or a whole plant.

Ingredient details, preparation and research

Source plant or material

Not tied to a single source plant.

Plant family / material: Not assigned: this record is defined by its chemical or product identity.

Forms and route

Oral phytosterol preparation studied in BPH. Oral route only unless a historical context is expressly separated.

Vitamins and minerals

No universal serving values apply to this formulation. A constituent being present does not establish nutritional adequacy or clinical benefit.

Absorption and preparation

Plant sterols are ordinarily poorly absorbed, but sitosterolemia changes their handling. A low average absorption rate does not make concentrated products safe for everyone.

Traditional and reported uses

  • A studied sterol preparation improved BPH symptom scores and urine flow over six months.

Contraindications and cautions

  • Have urinary symptoms assessed before use.
  • Ask a pharmacist to review the exact product and other medicines.
  • People with sitosterolemia accumulate plant sterols; seek specialist advice rather than adding sterol supplements.

Similar items and how they compare

  • Sterol-containing foods and pure beta-sitosterol

    They share sterol chemistry.

    Neither identifies the full phytosterol mixture used in the BPH trial.

Terms used in this card

BPH means benign prostatic hyperplasia, or noncancerous prostate enlargement.

Identity and composition

A beta-sitosterol-rich, phytosterol preparation studied orally for BPH. It is a mixture, not pure beta-sitosterol or a whole plant. Plant sterols are cholesterol-related compounds. The inspected trial abstract identifies a phytosterol mixture but does not give a complete batch specification.

What the human evidence can show

A placebo-controlled trial of 200 men found improved symptoms and flow, but no important decrease in prostate size. An older trial of a specified mixture cannot establish all products, long-term safety or prevention of complications.

Safety and limits

Have urinary symptoms assessed before use. Ask a pharmacist to review the exact product and other medicines. People with sitosterolemia accumulate plant sterols; seek specialist advice rather than adding sterol supplements.

Evidence limits

  • An older trial of a specified mixture cannot establish all products, long-term safety or prevention of complications.
  • A product-specific result cannot establish every commercial preparation.

Entry sources